NAD+NEURONUTRIENT=EVIDENCE BASED MODALITY!

💥EVIDENCE-BASE RESEARCHED MODALITY💥

🧠NAD+ NEURO NUTRIENT INFUSION🧠

💥TRADEMARKED AS: RESTORITROL IV NTR3 NEURO💥

💥5 Year Journey:

1. Unlocking the Neurobiological Mechanism of Addiction

2. Healing the Biological & Physiological Aspects of Addiction

3. So, Clients can Hyperfocus on Spiritual-Mental-Behavioral Recovery Programming

RESEARCH THESIS OUTLINE:

I. Foundational Case Precedent Background Publications:

1) Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms

2) Neuronutrient Amino-Acid Therapy Protects Against Reward Deficiency Syndrome: Dopaminergic Key to Homeostasis and Neuroplasticity’

II. Substance Use Disorder Addiction Research by Dr. Jay Bouldin

1) Addiction Defined & Functional Definitions of Addiction, Tolerance & Withdrawal

2) Research Informed Practice in the Treatment of Addiction

3) Neurobiological Effect & Affect of Addiction) Opioids the D2DR & Positive Reinforcement

5) Drugs, Receptors & Neurotransmitters: Facts &Science

6) 2018 Clinical Design Project Proposed

7) Combining Therapies are More Effective & Global Drug Trends

8) Medical Nutritional Deficiencies in Addiction

III. Neuroanatomy Limbic System & Reward Circuitry Neurophysiology

IV. Dopamine & Dopamine NTR: D2DR Receptor

1) D2DR Receptor Morphology in Addiction

2) D2DR Peptide 3D Structures in Addiction

3) D2DR IV NTR3 Peptide Mechanisms in Addiction

V. NAD+ Nicotinamide Adenine Dinucleotide & Addiction Utility

1) NAD+ History, Science, Biochemistry and Physiology

2) NAD+ Consumer Backgrounder: What is it and Why it is Vital

3) NAD+ Safety Profile and Chemical Manufacturing ROCHE

4) NAD+ Sobriety & Satiety in Addiction Peer Review Publication

5) NAD+ Clinical Trial in Patients with Addiction

VI. RESTORITROL: IV NTR3 NEURO THERAPY Research Design

1) Clinical Study Design, Abstract, Hypotheses, Aims, Goals, Claims, Budget

2) Submitted NIH-NIDA, SAMHSA Opioid Use Disorder Research

3) Full Patient Imaging & Interpretation Results from 3 Patient Pilot Study

VII. Commercialization: Pitch Deck, Marketing & Billing Reimbursements

1) Pitch Deck, Market Research, Demand, Websites, Domains, Social Media and NFTs,

2) FDA-IND 161206 & Expanded Use Access “Compassionate Use” Application Materials

3) USPTO Trademarks and Patent Materials 3 Provisional Patent Awards

NAD+ NEURO NUTRIENT INFUSION=RESTORITROL: IV NTR3 NEURO THERAPY: The Future of Addiction Recovery Infusion Healthcare!

#nad#ivtherapy#infusiontherapy#ivdrip#ivhydration#addiction#addictionrecovery#addictionmedicine#addictiontreatment#mentalhealth#php#infusion#nicotinamideadeninedinucleotide#substanceusedisorders#detoxification#behavioralhealth#substanceusedisorder#detox